Skip to main content

Oral B Subunit-Whole Cell Vaccine Against Cholera: From Basic Research to Successful Field Trial

  • Conference paper
Progress in Vaccinology

Part of the book series: Progress in Vaccinology ((VACCINOLOGY,volume 2))

  • 96 Accesses

Abstract

Cholera is an important cause of morbidity and mortality in many devel-oping countries. Cholera is also the prototype for a large group of diarrheal diseases—the “enterotoxic enteropathies”—which may be responsible for roughly half of all diarrheal disease episodes in the world. These dis¬eases are caused by various bacteria that produce one or more toxins, which by upsetting normal fluid transport processes in the gut give rise to watery diarrhea.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Black RE, Levine MM, Clements ML, et al: Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin. Infect Immun 1987; 55: 1116–1120.

    PubMed  CAS  Google Scholar 

  2. Clemens JD, Jertborn M, Sack DA, et al: Effect of neutralization of gastric acid on immune responses to an oral B subunit-killed whole-cell cholera vac¬cine. J Infect Dis 1986; 154: 175–178.

    Article  PubMed  CAS  Google Scholar 

  3. Clemens JD, Stanton BF, et al: B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity. J In-fect Dis 1987; 155: 79–85.

    Article  CAS  Google Scholar 

  4. Clemens JD,Sack DA, Harris JR, et al: Field trial of oral cholera vaccines in Bangladesh Lancet 1986; 2: 124–127

    Article  PubMed  CAS  Google Scholar 

  5. Holmgren J, Svennerholm A-M, Lonnroth I, et al: Development of improved cholera vaccine based on subunit toxoid. Nature 1977; 269: 602–604.

    Article  PubMed  CAS  Google Scholar 

  6. Holmgren J: Actions of cholera toxin and the prevention and treatment of cholera. Nature 1981; 292: 413–417.

    Article  PubMed  CAS  Google Scholar 

  7. Holmgren J, Svennerholm A-M: Cholera and the immune response. Progr Allergy 1983; 33: 106–119.

    CAS  Google Scholar 

  8. Jertborn M, Svennerholm A-M, Holmgren J: Gut mucosal, salivary and serum antitoxic and antibacterial antibody responses in Swedes after oral immuni¬zation with B subunit-whole cell cholera vaccine. Int Arch Allergy Appl Im-munol 1984; 75: 38–43.

    Article  CAS  Google Scholar 

  9. Levine MM, Kaper JB, Black RE, Clements ML: New knowledge on path-ogenesis of bacterial enteric infections as applied to vaccine development. Microbiol Rev 1983;47:510–550. 10.

    Google Scholar 

  10. Lycke N, Holmgren J: Long-term cholera antitoxin memory in the gut can be triggered to antibody formation associated with protection within hours of an oral challenge immunization. Scand J Immunol 1987; 25: 407–412.

    Article  PubMed  CAS  Google Scholar 

  11. Lycke N, Holmgren J: Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 1986; 59: 301–308.

    PubMed  CAS  Google Scholar 

  12. Pierce NF: The role of antigen form and function in the primary and secondary intestinal immune responses to cholera toxin and toxoid in rats. J Exp Med 1978; 148: 195–206.

    Article  PubMed  CAS  Google Scholar 

  13. Svennerholm A-M, Holmgren J: Synergistic protective effect in rabbits of im¬munization with V. cholerae lipopolysaccharide and toxin/toxoid. Infect Immun 1976; 13: 735–740.

    PubMed  CAS  Google Scholar 

  14. Svennerholm A-M, Sack DA, Holmgren J, Bardhan PK: Intestinal antibody responses after immunization with cholera B subunit. Lancet 1982; 1: 305–308.

    Article  PubMed  CAS  Google Scholar 

  15. Svennerholm A-M, Gothefors L, Sack DA, et al: Local and systemic antibody responses and immunological memory in humans after immunization with cholera B subunit by different routes. Bull WHO 1984; 62: 909–918.

    PubMed  CAS  Google Scholar 

  16. Svennerholm A-M, Jertborn M, Gothefors L, et al: Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J Infect Dis 1984; 149: 884–893.

    Article  PubMed  CAS  Google Scholar 

  17. Tayot J-L, Holmgren J, Svennerholm L, et al: Receptor-specific large scale purification of cholera toxin on silica beads derivatized with lyso-GM,-gan- glioside. Eur J Biochem 1981; 113: 249–258.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag New York Inc.

About this paper

Cite this paper

Holmgren, J., Clemens, J., Sack, D., Svennerholm, AM. (1989). Oral B Subunit-Whole Cell Vaccine Against Cholera: From Basic Research to Successful Field Trial. In: Talwar, G.P. (eds) Progress in Vaccinology. Progress in Vaccinology, vol 2. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3508-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-3508-8_14

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-96734-9

  • Online ISBN: 978-1-4612-3508-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics